NCT04873648

Brief Summary

Obesity presents a substantial economic burden in Jordan. Binge eating disorder (BED) and food addiction (FA) are the most common eating disorders associated with obesity. BED and FA most therapeutic approach is cognitive-behavioral therapy. Dopamine (DA) and serotonin (5HT) the major neurotransmitter responsible for FA and BED. Daily calorie restriction (CR) and intermittent calorie restriction (ICR) are two forms of diet therapy that can help weight loss. Prolong fasting increases lipolysis and elevates ketones bodies' levels in the brain led to a significant increase in the DA and 5HT. No prior human research has examined the effect of ICR (model 8:16) on DA and 5HT levels and weight reduction on obese with BED and FA. Therefore, A Randomized, controlled trial of 6 weeks follow-up will be used. A sample of 100 obese women will be selected to be randomly assigned to daily CR or ICR, or control group without FA or BED for a period of 6 weeks. Participants will be undergoing nutrition assessment, Anthropometrics assessment, food Addiction assessment (YFAS), binge eating assessment (BEDS-7), and hormonal level (DA\&5HT) at baseline and after 6 weeks. The investigators anticipated that CR and ICR (model8:16) will significantly induce DA\&5HT level changes and that ICR (model8:16) will be significantly more effective than CR in reducing BED \& FA.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 5, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

June 20, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

September 28, 2021

Status Verified

September 1, 2021

Enrollment Period

9 months

First QC Date

April 27, 2021

Last Update Submit

September 27, 2021

Conditions

Keywords

Eating DisordersIntermitted FastingObesityDopamineSerotonin

Outcome Measures

Primary Outcomes (4)

  • Dopamine serum level

    The level of serum dopamine in ng/ml at both baseline and 6 weeks of follow up

    Through study completion, an average of 1 year

  • Serotonin serum level

    The level of serum serotonin in ng/ml at both baseline and 6 weeks of follow up

    Through study completion, an average of 1 year

  • food addiction disorder

    by the diagnostic tool for food addiction - Yale Food Addiction Scale (YFAS), The content will be translated and the content validity will be assessed at both baseline and 6 weeks of follow-up. YFAS contains a 25-item self-report measure that includes mixed response categories (dichotomous and Likert-type format). The YFAS includes two scoring options: 1) a "symptom count" ranging from 0 to 7 that reflects the number of addiction-like criteria endorsed and 2) a dichotomous "diagnosis" that indicates whether a threshold of three or more "symptoms" plus clinically significant impairment or distress has been met. Food addiction can be "diagnosed" when three symptoms and clinically significant impairment or distress are present.

    Through study completion, an average of 1 year

  • binge eating disorder (BED)

    by the diagnostic tool, to assess BED, a previously translated and validated eating and weight patterns questionnaire (QEWP-5) will be used based on the new diagnostic and statistical manual of mental disorders-5 criteria. at both baseline and 6 weeks of follow up The screening was based on the diagnostic criteria of the DSM-5 In the original form of the QEWP-5 questionnaire, if the participant answered based on the following criteria, the participant is considered to be diagnosed with BED. * 8 and 9 if the participant answered (YES) (Binge eating) * 10, 2, 3, 4, 5, or 6 (At least one episode per a week in the last 3 months) * 11 (a through e) 3 or more items marked "YES" (At least 3 associated symptoms during binge-eating episodes) * 13 (4 0R 5) (Marked distress regarding binge eating)

    Through study completion, an average of 1 year

Study Arms (5)

food addiction and binge eating follow caloric reduced -intermitted fasting diet

EXPERIMENTAL

Obese women diagnosed with binge eating disorder and food addiction follow caloric reduced -intermitted fasting diet

Behavioral: caloric reduced -intermitted fasting diet

food addiction and binge eating follow caloric restriction diet

ACTIVE COMPARATOR

Obese women diagnosed with binge eating disorder and food addiction follow caloric restriction diet

Behavioral: Daily calorie restriction

binge eating disorder follow follow caloric reduced -intermitted fasting diet

EXPERIMENTAL

Obese women diagnosed with binge eating disorder follow caloric reduced -intermitted fasting diet

Behavioral: caloric reduced -intermitted fasting diet

binge eating disorder follow caloric restriction diet

ACTIVE COMPARATOR

Obese women diagnosed with binge eating disorder follow a caloric restriction diet

Behavioral: Daily calorie restriction

obese women without food addiction and binge eating follow caloric restriction diet

PLACEBO COMPARATOR

Obese women without eating disorder follow a caloric restriction diet

Behavioral: Control group

Interventions

obese women with food addiction and binge eating follow intermittent calorie restriction diet ( time-restricted eating - typically 16 -hour fasting and 8-hour eating)

Also known as: Treatment
binge eating disorder follow follow caloric reduced -intermitted fasting dietfood addiction and binge eating follow caloric reduced -intermitted fasting diet

obese women with food addiction and binge eating disorder follow a Daily calorie restriction diet

Also known as: Active comparative treatment
binge eating disorder follow caloric restriction dietfood addiction and binge eating follow caloric restriction diet
Control groupBEHAVIORAL

obese women without food addiction and binge eating disorder follow a Daily calorie restriction diet

obese women without food addiction and binge eating follow caloric restriction diet

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThe most affected group with obesity and may have food Addiction and/or binge eating disorders
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Females,
  • Aged between 20-40 yr,
  • Premenopausal,
  • BMI(\>30 kg/m)

You may not qualify if:

  • Male
  • Females aged \<20-40\< yr,
  • Menopausal,
  • BMI(\<30 kg/m)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zainb zaiter clinic

Amman, Jordan

RECRUITING

Related Publications (11)

  • Adams RC, Sedgmond J, Maizey L, Chambers CD, Lawrence NS. Food Addiction: Implications for the Diagnosis and Treatment of Overeating. Nutrients. 2019 Sep 4;11(9):2086. doi: 10.3390/nu11092086.

    PMID: 31487791BACKGROUND
  • Ajlouni K, Jaddou H, Batieha A. Obesity in Jordan. Int J Obes Relat Metab Disord. 1998 Jul;22(7):624-8. doi: 10.1038/sj.ijo.0800637.

    PMID: 9705020BACKGROUND
  • Allen GF, Ullah Y, Hargreaves IP, Land JM, Heales SJ. Dopamine but not l-dopa stimulates neural glutathione metabolism. Potential implications for Parkinson's and other dopamine deficiency states. Neurochem Int. 2013 Apr;62(5):684-94. doi: 10.1016/j.neuint.2012.12.004. Epub 2012 Dec 19.

    PMID: 23261515BACKGROUND
  • Avena NM, Bocarsly ME, Hoebel BG, Gold MS. Overlaps in the nosology of substance abuse and overeating: the translational implications of "food addiction". Curr Drug Abuse Rev. 2011 Sep;4(3):133-9. doi: 10.2174/1874473711104030133.

    PMID: 21999687BACKGROUND
  • Bastani A, Rajabi S, Kianimarkani F. The Effects of Fasting During Ramadan on the Concentration of Serotonin, Dopamine, Brain-Derived Neurotrophic Factor and Nerve Growth Factor. Neurol Int. 2017 Jun 23;9(2):7043. doi: 10.4081/ni.2017.7043. eCollection 2017 Jun 23.

    PMID: 28713531BACKGROUND
  • Bello NT, Hajnal A. Dopamine and binge eating behaviors. Pharmacol Biochem Behav. 2010 Nov;97(1):25-33. doi: 10.1016/j.pbb.2010.04.016. Epub 2010 Apr 24.

    PMID: 20417658BACKGROUND
  • Brownley KA, Berkman ND, Sedway JA, Lohr KN, Bulik CM. Binge eating disorder treatment: a systematic review of randomized controlled trials. Int J Eat Disord. 2007 May;40(4):337-48. doi: 10.1002/eat.20370.

    PMID: 17370289BACKGROUND
  • Camandola S, Mattson MP. Brain metabolism in health, aging, and neurodegeneration. EMBO J. 2017 Jun 1;36(11):1474-1492. doi: 10.15252/embj.201695810. Epub 2017 Apr 24.

    PMID: 28438892BACKGROUND
  • Citrome L. A primer on binge eating disorder diagnosis and management. CNS Spectr. 2015 Dec;20 Suppl 1:44-50; quiz 51. doi: 10.1017/S1092852915000772.

    PMID: 26683528BACKGROUND
  • da Luz FQ, Hay P, Gibson AA, Touyz SW, Swinbourne JM, Roekenes JA, Sainsbury A. Does severe dietary energy restriction increase binge eating in overweight or obese individuals? A systematic review. Obes Rev. 2015 Aug;16(8):652-65. doi: 10.1111/obr.12295. Epub 2015 Jun 11.

    PMID: 26094791BACKGROUND
  • Davis C. A commentary on the associations among 'food addiction', binge eating disorder, and obesity: Overlapping conditions with idiosyncratic clinical features. Appetite. 2017 Aug 1;115:3-8. doi: 10.1016/j.appet.2016.11.001. Epub 2016 Nov 2.

    PMID: 27816464BACKGROUND

MeSH Terms

Conditions

Feeding and Eating DisordersIntermittent FastingObesity

Interventions

TherapeuticsControl Groups

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersFastingFeeding BehaviorBehaviorOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody Weight

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Rima H Mashal, Assoc. Prof

    The University of Jordan

    STUDY CHAIR

Central Study Contacts

Zainab A Zueter, phD

CONTACT

Rima H Mashal, Assoc. Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 27, 2021

First Posted

May 5, 2021

Study Start

June 20, 2021

Primary Completion

March 30, 2022

Study Completion

June 30, 2022

Last Updated

September 28, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

The center (Jordan University hospital) where the study conducted emphasis of maintaining privacy and confidentiality of the participants' data

Locations